NASDAQ:AXGN

Axogen Stock Insider Trading

Healthcare > Medical - Devices

Buy AXGN

*Your capital is at risk

$40.63

+1.17 (+2.97%)

At Close: Jun 03, 2026

AxoGen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -70.16. In total, the insiders bought 852.59K and sold 464.52K AXGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-70.16
● Buy	852.59K shares
● Sell	464.52K shares
59% Buy Activity Strong Negative Correlation
Sell Signal High Confidence May 07, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -70.16. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 26, 2026 Buy	Restricted Stock Units A-Award	Hartley Lindsey Marie CFO	C-Suite Officer	23 000 Value: $733.7K
Feb 26, 2026 Sell	Common Stock F-InKind	Hartley Lindsey Marie CFO	C-Suite Officer	6 630 Value: $211.5K
Feb 26, 2026 Buy	Common Stock A-Award	Hartley Lindsey Marie CFO	C-Suite Officer	17 453 Value: $556.8K
Feb 22, 2026 Buy	Restricted Stock Units A-Award	Hartley Lindsey Marie CFO	C-Suite Officer	17 500 Value: $711.0K
Feb 22, 2026 Sell	Common Stock F-InKind	Hartley Lindsey Marie CFO	C-Suite Officer	6 704 Value: $237.2K
Feb 22, 2026 Buy	Common Stock A-Award	Hartley Lindsey Marie CFO	C-Suite Officer	17 500 Value: $711.0K
Dec 16, 2025 Sell	Common Stock S-Sale	Weiler Kathy Johnson Director	Director	6 580 Value: $194.4K
Dec 16, 2025 Sell	Common Stock S-Sale	Weiler Kathy Johnson Director	Director	21 825 Value: $644.9K
Dec 16, 2025 Buy	Common Stock M-Exempt	Weiler Kathy Johnson Director	Director	18 248 Value: $128.5K
Dec 16, 2025 Sell	Common Stock S-Sale	Weiler Kathy Johnson Director	Director	18 248 Value: $539.2K
Dec 16, 2025 Buy	Common Stock M-Exempt	Weiler Kathy Johnson Director	Director	21 825 Value: $151.7K
Dec 16, 2025 Buy	Stock Option (right to purchase) M-Exempt	Wendell Amy Mcbride Director	Director	20 436 Value: $128.7K
Dec 16, 2025 Buy	Stock Option (right to purchase) M-Exempt	Wendell Amy Mcbride Director	Director	5 000 Value: $44.8K
Dec 16, 2025 Buy	Employee Stock Option (right to purchase) M-Exempt	Weiler Kathy Johnson Director	Director	21 825 Value: $151.7K
Dec 16, 2025 Buy	Employee Stock Option (right to purchase) M-Exempt	Weiler Kathy Johnson Director	Director	18 248 Value: $128.5K
Dec 16, 2025 Buy	Common Stock M-Exempt	Wendell Amy Mcbride Director	Director	18 248 Value: $128.5K
Dec 16, 2025 Sell	Common Stock S-Sale	Wendell Amy Mcbride Director	Director	5 000 Value: $146.6K
Dec 16, 2025 Buy	Common Stock M-Exempt	Wendell Amy Mcbride Director	Director	20 436 Value: $128.7K
Dec 16, 2025 Sell	Common Stock S-Sale	Wendell Amy Mcbride Director	Director	20 436 Value: $599.0K
Dec 16, 2025 Buy	Common Stock M-Exempt	Wendell Amy Mcbride Director	Director	5 000 Value: $44.8K
Dec 16, 2025 Sell	Common Stock S-Sale	Wendell Amy Mcbride Director	Director	18 248 Value: $534.9K
Dec 16, 2025 Buy	Stock Option (right to purchase) M-Exempt	Wendell Amy Mcbride Director	Director	18 248 Value: $128.5K
Dec 15, 2025 Sell	Common Stock S-Sale	Hartley Lindsey Marie CFO	C-Suite Officer	14 812 Value: $442.3K
Dec 15, 2025 Buy	Common Stock M-Exempt	Hartley Lindsey Marie CFO	C-Suite Officer	14 812 Value: $122.5K
Dec 15, 2025 Buy	Employee Stock Option (right to purchase) M-Exempt	Hartley Lindsey Marie CFO	C-Suite Officer	14 812 Value: $122.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AXOGEN

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for te...

Read Full Profile Here